Breast percentage density estimations with synthesized 2D breast imaging versus standard-dose mammograms.
Synthesized digital breast tomosynthesis (DBT) images are generally comparable to images from standard-dose mammograms, according to a study published in Radiology.
Researchers from the University of Pennsylvania in Philadelphia compared the quality and agreement between automated estimates of breast density made from standard-dose versus synthetic digital mammograms among women undergoing breast cancer screening.
The researchers evaluated images taken from 3,668 negative digital breast tomosynthesis (DBT) screening examinations consecutively performed over a four-month period, in which both standard-dose and synthesized mammograms were available. Agreement between density estimates was assessed by using Pearson correlation, linear regression, and Bland-Altman analysis. Differences were evaluated by using the paired Student t test.
Results showed that breast percentage density (PD) estimates from synthetic and standard-dose mammograms were highly correlated, and the 95% Bland-Altman limits of agreement between PD estimates were −6.4% to 9.9%. Synthetic mammograms had PD estimates by an average of 1.7% higher than standard-dose mammograms, with a larger disagreement by 1.56% in women with highly dense breast tissue.
“Fully automated estimates of breast density made from synthetic mammograms are generally comparable to those made from standard-dose mammograms,” the researchers concluded. “This may be important, as standard two-dimensional mammographic images are increasingly being replaced by synthetic mammograms in DBT screening in an attempt to reduce radiation dose.”
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.